Literature DB >> 34862212

Seeing what others see while thinking what others have not.

Anton Emmanuel, Gerrard Phillips1.   

Abstract

Entities:  

Year:  2021        PMID： 34862212      PMCID： PMC8806308          DOI： 10.7861/clinmed.ed.21.6.1

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

1.  The unspoken benefit of participation in a clinical trial.

Authors:  Konstantin Schwarz; Sathish Parasuraman; Satnam Singh; John D Horowitz; Dana K Dawson; Michael P Frenneaux
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

2.  'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV).

Authors:  Amitava Banerjee; Laura Pasea; Sinduja Manohar; Alvina G Lai; Eade Hemingway; Izaak Sofer; Michail Katsoulis; Harpreet Sood; Andrew Morris; Caroline Cake; Natalie K Fitzpatrick; Bryan Williams; Spiros Denaxas; Harry Hemingway
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

3.  The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT.

Authors:  Mohamed S El-Sayed; Godfrey N Wechie; Chen Sheng Low; Oludolapo Adesanya; Nikhil Rao; Vincent J Leung
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

Review 4.  VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme.

Authors:  Tim Chevassut; Beverley J Hunt; Sue Pavord
Journal:  Clin Med (Lond)       Date:  2021-10-13       Impact factor: 2.659

5.  The art and science of the thrombosis with thrombocytopenia syndrome.

Authors:  Cheng-Hock Toh
Journal:  Clin Med (Lond)       Date:  2021-10-12       Impact factor: 2.659
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.